Fubotv earnings beat by $0.10, revenue topped estimates
Centene (NYSE:CNC) Corp’s stock reached a new 52-week low, closing at 25.11 USD. According to InvestingPro data, the healthcare giant, with a market capitalization of $12.37 billion and annual revenue of $159.56 billion, is currently trading at compelling valuations with a P/E ratio of 6.18. This milestone reflects a significant downturn for the healthcare company, which has experienced a 66.6% decrease in its stock value over the past year. The decline underscores the challenges Centene has faced amidst a volatile market environment and shifting industry dynamics. However, InvestingPro analysis indicates the stock is currently undervalued, with technical indicators suggesting oversold conditions. Notably, management has been actively buying back shares, demonstrating confidence in the company’s fundamentals. As investors assess the company’s future prospects, the stock’s performance remains a focal point, highlighting the broader trends affecting the healthcare sector. For deeper insights into Centene’s valuation and 14 additional exclusive ProTips, explore the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Centene Corporation reported its second-quarter 2025 results, revealing an adjusted loss per share of $0.16, missing the forecasted earnings per share of $0.23. Despite the earnings miss, the company noted strong revenue performance and expressed a positive outlook for future profitability. Additionally, Centene announced the resignation of Director Wayne S. DeVeydt, reducing the board size to ten members. The company clarified that his departure was not due to any dispute or disagreement with the board or company policies. In another development, Cantor Fitzgerald downgraded Centene’s stock rating from Overweight to Neutral, citing macroeconomic uncertainty in the Health Insurance Exchange and Medicaid markets. The investment firm expressed particular concern about Centene’s earnings exposure to the Health Insurance Exchange segment. Meanwhile, eHealth (NASDAQ:EHTH), Inc. appointed Derrick Duke as its new Chief Executive Officer, effective September 18, 2025, following the retirement of Fran Soistman. Soistman will remain on the board and serve as an executive advisor through the end of 2025 to facilitate the leadership transition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.